Scriptaid, a Novel Histone Deacetylase Inhibitor, Protects Against Traumatic Brain Injury via Modulation of PTEN and AKT Pathway: Scriptaid Protects Against TBI via AKT

Traumatic brain injury (TBI) is a leading cause of motor and cognitive deficits in young adults for which there is no effective therapy. The present study characterizes the protective effect of a new histone deacetylase inhibitor, Scriptaid (Sigma-Aldrich Corporation, St. Louis, MO), against injury...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wang, Guohua, Jiang, Xiaoyan, Pu, Hongjian, Zhang, Wenting, An, Chengrui, Hu, Xiaoming, Liou, Anthony Kian-Fong, Leak, Rehana K., Gao, Yanqin, Chen, Jun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2012
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3557358/
https://ncbi.nlm.nih.gov/pubmed/23132328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-012-0157-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak